Market Cap (In INR)
5.48 Billion
Revenue (In INR)
3.67 Billion
Net Income (In INR)
172.46 Million
Avg. Volume
237.36 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 89.5-131.4
- PE
- -
- EPS
- -
- Beta Value
- 0.566
- ISIN
- INE518E01015
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Chandrashekhar Mainde
- Employee Count
- -
- Website
- https://www.zimlab.in
- Ipo Date
- 2022-11-25
- Details
- ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.
More Stocks
-
ECDA
-
BCCL
-
SSVFF
-
GNFC
-
WRPTWarpSpeed Taxi Inc.
WRPT
-
CENTURYPLYCentury Plyboards (India) Limited
CENTURYPLY
-
SDRC
-
NNN